Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis

被引:20
作者
Sola-Valls, Nuria [1 ,2 ]
Vicente-Pascual, Mikel [1 ,2 ]
Blanco, Yolanda [1 ,2 ]
Solana, Elisabeth [1 ,2 ]
Llufriu, Sara [1 ,2 ]
Martinez-Heras, Eloy [1 ,2 ]
Martinez-Lapiscina, Elena H. [1 ,2 ]
Sepulveda, Maria [1 ,2 ]
Pulido-Valdeolivas, Irene [1 ,2 ]
Zubizarreta, Irati [1 ,2 ]
Saiz, Albert [1 ,2 ]
机构
[1] Univ Barcelona, Ctr Neuroimmunol, Serv Neurol, Hosp Clin Barcelona, Villarroel 170, E-08036 Barcelona, Spain
[2] Univ Barcelona, Neuroimmunol Program, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Villarroel 170, E-08036 Barcelona, Spain
关键词
Multiple sclerosis; Clinical monitoring; Expanded disability status scale; Patient determined disease steps; Telephone questionnaire; Patient-reported outcome; FUNCTIONAL-SYSTEMS; IMPAIRMENT; EDSS; RELIABILITY; AGREEMENT; VALIDITY;
D O I
10.1016/j.msard.2018.11.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Expanded Disability Status Scale (EDSS) and Patient Determined Disease Steps (PDDS) are two of the most widely disability scales used in multiple sclerosis (MS). When physical visits are unavailable, remote evaluation through telephone interview may be helpful. We aimed to translate both scales into Spanish, and to 1) validate the telephone EDSS and PDDS, and 2) explore the association pattern between both telephone questionnaires. Methods: 103 patients underwent a neurological examination to generate the EDSS and completed the PDDS questionnaire. Telephone questionnaires (EDSS, PDDS) were performed within 15 days. Feasibility and psychometric properties of both telephone questionnaires included internal consistency, acceptability, inter-rater agreement and validity. Test-retest reliability was evaluated in 36 patients. Results: Both scales showed excellent internal consistency and test-retest reliability. The agreement between conventional and telephone assessments in ambulatory impaired patients (EDSS > 4.0) was good for EDSS (kappa = 0.72) and excellent for PDDS (kappa = 0.93); fully ambulatory patients (EDSS <= 4.0) showed lower values (kappa = 0.24, and 0.54, respectively). Full agreement was higher for telephone PDDS than telephone EDSS (78% vs 44%). Overestimation of disability was more frequent in fully ambulatory patients. Strong correlation was found between telephone questionnaires (rho = 0.88; p < 0.001). The pattern of association was not isomorphic, but a PDDS cut-off of 3 identified with high accuracy patients with ambulatory impairment. Discussion: Telephone EDSS and PDDS questionnaires for Spanish patients are valid tools to assess disability status in MS and offer complementary information. Patients with ambulatory impairment are those who benefit the most from a remote assessment.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 22 条
[1]   INTERRATER RELIABILITY IN ASSESSING FUNCTIONAL-SYSTEMS AND DISABILITY ON THE KURTZKE SCALE IN MULTIPLE-SCLEROSIS [J].
AMATO, MP ;
FRATIGLIONI, L ;
GROPPI, C ;
SIRACUSA, G ;
AMADUCCI, L .
ARCHIVES OF NEUROLOGY, 1988, 45 (07) :746-748
[2]   Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis [J].
Bove, Riley ;
Bevan, Carolyn ;
Crabtree, Elizabeth ;
Zhao, Chao ;
Gomez, Refujia ;
Garcha, Priya ;
Morrissey, John ;
Dierkhising, Jason ;
Green, Ari J. ;
Hauser, Stephen L. ;
Cree, Bruce A. C. ;
Wallin, Mitchell T. ;
Gelfand, Jeffrey M. .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (11) :1526-1534
[3]  
Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1177/135245850100700311
[4]   Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial [J].
Calabresi, Peter A. ;
Radue, Ernst-Wilhelm ;
Goodin, Douglas ;
Jeffery, Douglas ;
Rammohan, Kottil W. ;
Reder, Anthony T. ;
Vollmer, Timothy ;
Agius, Mark A. ;
Kappos, Ludwig ;
Stites, Tracy ;
Li, Bingbing ;
Cappiello, Linda ;
von Rosenstiel, Philipp ;
Lublin, Fred D. .
LANCET NEUROLOGY, 2014, 13 (06) :545-556
[5]  
Cheng EM, 2001, MULT SCLER, V7, P405, DOI 10.1191/135245801701566989
[6]   Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects [J].
Cohen, Jeffrey A. ;
Reingold, Stephen C. ;
Polman, Chris H. ;
Wolinsky, Jerry S. .
LANCET NEUROLOGY, 2012, 11 (05) :467-476
[7]   Clinically meaningful performance benchmarks in MS Timed 25-Foot Walk and the real world [J].
Goldman, Myla D. ;
Motl, Robert W. ;
Scagnelli, John ;
Pula, John H. ;
Sosnoff, Jacob J. ;
Cadavid, Diego .
NEUROLOGY, 2013, 81 (21) :1856-1863
[8]   A questionnaire to assess neurological impairment in multiple sclerosis [J].
Goodin, DS .
MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (05) :444-451
[9]   DISEASE STEPS IN MULTIPLE-SCLEROSIS - A SIMPLE APPROACH TO EVALUATE DISEASE PROGRESSION [J].
HOHOL, MJ ;
ORAV, EJ ;
WEINER, HL .
NEUROLOGY, 1995, 45 (02) :251-255
[10]   Disease steps in multiple sclerosis: a longitudinal study comparing Disease Steps and EDSS to evaluate disease progression [J].
Hohol, MJ ;
Orav, EJ ;
Weiner, HL .
MULTIPLE SCLEROSIS, 1999, 5 (05) :349-354